American Journal of Preventive Cardiology
Publisher: Elsevier · ISSN 2666-6677 · 95 articles
- Change in cascade of care among individuals with hypertension – India hypertension control initiative, 2018-2024
- Changes in statin therapy eligibility under the 2026 versus 2018 dyslipidemia guidelines
- Risk–Treatment Discordance and Fatal Cardiovascular Disease: A Nationwide Analysis Using PREVENT Thresholds
- Beyond the “Power of Zero”: Rethinking coronary calcium scoring in the AI Era
- Beyond place: Neighborhood deprivation, cardiometabolic health, and the life course origins of hypertensive disorders of pregnancy
- Carotid intima media thickness: A hazy window into cardiovascular health
- Waterpipe smoking and cardiovascular mortality: Challenging the safety Myth
- Examining patient-level factors associated with statin initiation: Applying the smallest worthwhile difference to the art of shared decision making
- Don’t sleep on the other beds: Atherosclerosis across heart, brain, and limbs
- Cardiovascular health and depression in the postpartum period: A blind spot in postpartum care
- From risk factor to infrastructure: reimagining nutrition for the cardiovascular-kidney-metabolic era
- Scaling hypertension control across India: five years of community level evidence from the Indian hypertension control initiative (IHCI)
- WHO HEARTS programs in high-income countries: Implementation, outcomes, and implications for global hypertension control
- Heterogeneous competing causes of death and transportability of the PREVENT equations
- Dyslipidemia management in athletes: A comparative commentary on the 2026 ACC/AHA/Multisociety Guideline and contemporary sports cardiology recommendations
- The coverage gap in PREVENT: Why cardiovascular risk prediction needs a lab-free complement
- Transferability of nurse-led interventions for cardiovascular health across diverse nursing roles in primary and community settings: Practice implications and solutions from a scoping review
- Associations of exclusive e-cigarette use and dual use of e-cigarettes and combustible cigarettes with prevalent and incident hypertension: A systematic review and meta-analysis
- Clinical considerations on the use of evinacumab for the treatment of homozygous familial hypercholesterolemia
- Association of social drivers of health with differential incidence of cardiovascular disease in young adults
- Incretin therapy prescription in a high cardiovascular risk population: Insights from a cardiology-based cardiometabolic program
- A prospective study of plasma levels of asprosin and incident type 2 diabetes in postmenopausal women
- Life’s essential 8 and incident major adverse cardiovascular events in Korea: A nationwide cohort study
- Primary prevention statin eligibility for U.S. adults under the 2026 ACC/AHA dyslipidemia guideline
- Firearm use and cardiovascular risk factors in the United States
- Associations of traumatic brain injury with incident cardiovascular disease: Results from the atherosclerosis risk in communities (ARIC) study
- Real-world prescribing patterns of SGLT2 inhibitors and GLP-1 receptor agonists in Type 2 diabetes with various ASCVD subtypes from a large tertiary referral center
- Performance of the PREVENT heart failure risk score and correlation with microvascular dysfunction and coronary plaque burden in patients with rheumatoid arthritis
- Real-world treatment adherence and persistence among patients initiating inclisiran or PCSK9 mAbs
- Implementation of an EHR-supported multidisciplinary lipid management program for suspected familial hypercholesterolemia: Early clinical and implementation outcomes